Deterioration of renal function by chronic heart failure is associated with congestion and oxidative stress in the tubulointerstitium

Internal Medicine

Volumn 50, Issue 23, 2011, Pages 2877-2887

  Tanaka, Marenao ^a   Yoshida, Hideaki ^a   Furuhashi, Masato ^a   Togashi, Nobuhiko ^a   Koyama, Masayuki ^a   Yamamoto, Satoshi ^a   Yamashita, Tomohisa ^a   Okazaki, Yusuke ^a   Ishimura, Shutaro ^a   Ota, Hideki ^a   Hasegawa, Tadashi ^a   Miura, Tetsuji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic heart failure; Oxidative stress; Renal dysfunction; Tubulointerstitial damage; Venous congestion

Indexed keywords

CD68 ANTIGEN; RAC1 PROTEIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CAPILLARY; CELL INVASION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; INTERSTITIAL NEPHRITIS; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY TUBULE; KIDNEY TUBULE CAPILLARY; LONGITUDINAL STUDY; MACROPHAGE; MALE; NEPHROSCLEROSIS; NITROSYLATION; OXIDATIVE STRESS; RETROSPECTIVE STUDY; VENOUS CONGESTION;

ADULT; AGED; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; HYPEREMIA; KIDNEY FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; OXIDATIVE STRESS; RETROSPECTIVE STUDIES;

EID: 82855162668     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5925     Document Type: Article

References (43)

1. Hunt SA, Abraham WT, Chin MH, et al. ACCF/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Circulation 112: e154-e235, 2005.
2. Fuster V, Gersh BJ, Giuliani ER, et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47: 525-531, 1981.
3. Diaz RA, Obasohan A, Oakley CM, et al. Prediction of outcome in dilated cardiomyopathy. Br Heart J 58: 393-399, 1987.
4. Ogasawara S, Sekiguchi M, Hiroe M, et al. Prognosis of dilated cardiomyopathy: From a retrospective to a prospective study employing multivariate analysis. Jpn Circ J 51: 699-706, 1987.
5. Jessup M, Abraham WT, Casey DE, et al. 2009 Focus Update: ACCF/AHA Guidelines for Diagnosis and Management of Heart Failure in Adults. Circulation 119: 1977-2016, 2009.
6. Ljungman S, Laragh JH, Cody RJ, et al. Role of the kidney in congestive heart failure: Relation ship of cardiac index to kidney function. Drug 39: 10-24, 1990.
7. Tanaka K, Ito M, Kodama M, et al. Longitudinal change in renal function in patients with idiopathic dilated cardiomyopathy without renal insufficiency at initial diagnosis. Circ J 71: 1927-1931, 2007.
8. Heywood JT. Cardiorenal syndrome: Lessons from the ADHERE database and treatment options. Heart Fail Rev 9: 195-201, 2004.
9. Bongartz LG, Cramer MJ, Doevendans PA, et al. The severe cardiorenal syndrome 'Guyton revisited'. Eur Heart 26: 11-17, 2005.
10. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulatoin 102: 203-210, 2000.
11. Damman K, Navis G, Voor AA, et al. Worsening renal function and prognosis in heart failure: systemic review and meta-analysis. J Card Fail 13: 599-608, 2007.
12. Smilde TD, Hillege HL, Navis G, et al. Impaired renal function in patients with ischemic and non-ischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J 148: 165-172, 2004.
13. Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53: 589-596, 2009.
14. Damman K, Deursen V, Navis G, et al. Increase central venous pressure is associated with inpaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53: 582-588, 2009.
15. Imai E, Horio M, Yamagata K, et al. Slower decline of glomerular filtration rate in Japanese general population: A longitudinal 10- year follow-up study. Hypertens Res 31: 433-441, 2008.
16. Agata J, Ura N, Yoshida H, et al. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensinconverting enzyme. Hypertens Res 29: 865-874, 2006.
17. Namikoshi T, Satoh M, Horie H, et al. Implication of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy. Nephron Physiol 10: 9-16, 2006.
18. Damman K, Voor AA, Hillege HL, et al. Congestion in chronic heart systemic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 12: 974-982, 2010.
19. Damman K, Navis G, Smilde TD, et al. Decrease cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9: 872-878, 2007.
20. Maeder MT, Holst DP, Kaye DM, et al. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail 14: 824-830, 2008.
21. Nohria A, Hasselblad V, Stebbins A, et al. Cariorenal interactions. J Am Coll Cardiol 51: 1268-1274, 2008.
22. Testani JM, Khera AV, St John, et al. Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol 105: 511-516, 2010.
23. Winton FR. The influence of venous pressure on the isolated mammalian kidney. J Physiol 72: 49-61, 1931.
24. D'Cruz IA, Khouzam RN. Update on echocardiography of the inferior vena cava. Echocardiography 22: 543-545, 2005.
25. Arthur M, Landolfo C, Wade M, et al. Inferior vena cava diameter (IVCD) measured with transesophageal echocardiography (TEE) can be used to derive the central pressure (CVP) in anesthetized mechanically ventilated patients. Echocardiography 29: 140-149, 2009.
26. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20: 1-17, 1992.
27. Bohle A, Mackensen-Haen S, Wehrmann M, et al. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 19: 191-195, 1996.
28. Lüss H, Mitrovic V, Seferovic PM, et al. Renal effects of ularitide in patients with decompensated heart failure. Am Heart J 155: e1012-e1018, 2008.
29. Seeto RK, Fenn B, Rocky DC, et al. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 109: 109-113, 2000.
30. Badalamenti S, Granziani G, Salerno F, et al. Hepatrorenal syndrome. New perspectives in pathogenesis and treatment. Arch Intern Med 153: 1957-1967, 1993.
31. Castells A, Salo J, Phanas R, et al. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study. Hepatology 20: 584-591, 1994.
32. Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 52: 206-210, 2010.
33. Nangaku M, Imai R, Miyata T, et al. Hypoxia and hypoxia- inducible factor in renal disease. Nephron Exp Nephrol 110: e1-e7, 2008.
34. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17-25, 2006.
35. Moncada S, Palmer RM, Higgs EA, et al. Nitric oxide: physiology, pathology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
36. 2: a pulse radiolysis study. Free Radic Biol Med 19: 505-510, 1995.
37. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 18: 195-199, 1993.
38. Ohshima H, Friesen M, Brouet I, et al. Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem Tox 28: 647-652, 1990.
39. Beckman JS, Ye YZ, Anderson P, et al. Extensive nitration of protein tyrosines observed in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 375: 81-88, 1994.
40. Herrlin B, Sylven C. Increase arterial oxygen content-an important compensatory mechanism in chronic moderated heart failure. Cardiovasc Res 25: 384-390, 1991.
41. De Gennaro L, Brunetti ND, Cuculo A, et al. Systemic inflammation in nonischemic dilated cardiomyopathy. Heart Vesseles 23: 445-450, 2008.
42. Quinn MT, Evans T, Loetterle LR, et al. Translocation of rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components. J Biol Chem 268: 20983-20987, 1993.
43. Bokoch GM, Diebold BA. Current molecular models for NADPH oxidase regulation by rac GTPase. Blood 100: 2692-2696, 2002.